Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials

Fig. 3

Estimate of difference from baseline in systolic blood pressure (SBP) at Week 26 by subgroup. Data are presented as n1, n2, and n3 where n1 = number of patients in the placebo group, n2 = number of patients in the ertugliflozin 5 mg group, and n3 = number of patients in the ertugliflozin 15 mg group. BMI body mass index, eGFR estimated glomerular filtration rate, HbA1c glycated hemoglobin

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840